Loading clinical trials...
Loading clinical trials...
PET/CT Molecular Imaging of Angiogenesis in Pulmonary or Head and Neck Cancers Prior to or During Chemotherapy Including Agent With Antiangiogenic Effect. A Prospective Multicentric Study of Efficacy and Tolerability.
Conditions
Interventions
radiopharmaceutical (Flotegatide (18F) or RGD (68Ga)
Locations
1
France
Hôpital Tenon - Assistance Publique-Hôpitaux de Paris
Paris, France
Start Date
March 20, 2015
Primary Completion Date
September 20, 2018
Completion Date
September 20, 2018
Last Updated
July 19, 2022
NCT05969860
NCT04491942
NCT03727061
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions